Twist Bioscience Corp (NASDAQ:TWST)
| 19.20 Delayed Data As of 4:00pm ET |  -1.06 / -5.23%Today’s Change | 11.46 Today|||52-Week Range 40.50 | -19.36% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.2B |
Company Description
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Contact Information
Twist Bioscience Corp. 681 Gateway Boulevard San Francisco California 94080 |
Employees
Shareholders
| Mutual fund holders | 72.82% |
| Other institutional | 40.87% |
| Individual stakeholders | 13.98% |
Top Executives
| Emily Marine Leproust | Chairman & Chief Executive Officer |
| Patrick J. Finn | President & Chief Operating Officer |
| James M. Thorburn | Chief Financial Officer |
| Siyuan Chen | Chief Technology Officer |
| Nimisha Srivastava | Senior Vice President-Research & Development |
